{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:54Z","timestamp":1740107634142,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00467-023-06093-8","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T20:28:46Z","timestamp":1689884926000},"page":"603-607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Constipation and hemolytic uremic syndrome"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7405-8569","authenticated-orcid":false,"given":"Brendan","family":"Crawford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige","family":"Strebeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Saccente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"6093_CR1","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00467-018-4105-1","volume":"34","author":"M Khalid","year":"2019","unstructured":"Khalid M, Andreoli S (2019) Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol 34:2495\u20132507","journal-title":"Pediatr Nephrol"},{"key":"6093_CR2","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-021-05370-8","volume":"37","author":"LMP Palma","year":"2022","unstructured":"Palma LMP, Vaisbich-Guimar\u00e3es MH, Sridharan M et al (2022) Thrombotic microangiopathy in children. Pediatr Nephrol 37:1967\u20131980","journal-title":"Pediatr Nephrol"},{"key":"6093_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G et al (2016) An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 31:15\u201339","journal-title":"Pediatr Nephrol"},{"key":"6093_CR4","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/cid\/cix959","volume":"65","author":"AL Shane","year":"2017","unstructured":"Shane AL, Mody RK, Crump JA et al (2017) 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 65:1963\u20131973","journal-title":"Clin Infect Dis"},{"key":"6093_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S2468-1253(17)30160-7","volume":"2","author":"SB Freedman","year":"2017","unstructured":"Freedman SB, Xie J, Nettel-Aguirre A et al (2017) Enteropathogen detection in children with diarrhoea, or vomiting, or both, comparing rectal flocked swabs with stool specimens: an outpatient cohort study. Lancet Gastroenterol Hepatol 2:662\u2013669","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"6093_CR6","doi-asserted-by":"publisher","first-page":"e02077","DOI":"10.1128\/JCM.02077-18","volume":"57","author":"S Jean","year":"2019","unstructured":"Jean S, Yarbrough ML, Anderson NW, Burnham C-AD (2019) Culture of Rectal swab specimens for enteric bacterial pathogens decreases time to test result while preserving assay sensitivity compared to bulk fecal specimens. J Clin Microbiol 57:e02077-e2018","journal-title":"J Clin Microbiol"},{"key":"6093_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/cid\/ciy584","volume":"67","author":"JM Miller","year":"2018","unstructured":"Miller JM, Binnicker MJ, Campbell S et al (2018) A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 67:813\u2013816","journal-title":"Clin Infect Dis"},{"key":"6093_CR8","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00467-016-3420-7","volume":"31","author":"KL Wijnsma","year":"2016","unstructured":"Wijnsma KL, van Bommel SA, van der Velden T et al (2016) Fecal diagnostics in combination with serology: best test to establish STEC-HUS. Pediatr Nephrol 31:2163\u20132170","journal-title":"Pediatr Nephrol"},{"key":"6093_CR9","first-page":"1","volume":"58","author":"LH Gould","year":"2009","unstructured":"Gould LH, Bopp C, Strockbine N et al (2009) Recommendations for diagnosis of shiga toxin\u2013producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 58:1\u201314","journal-title":"MMWR Recomm Rep"},{"key":"6093_CR10","doi-asserted-by":"publisher","first-page":"e025950","DOI":"10.1136\/bmjopen-2018-025950","volume":"9","author":"GAM Tarr","year":"2019","unstructured":"Tarr GAM, Lin CY, Lorenzetti D et al (2019) Performance of commercial tests for molecular detection of Shiga toxin-producing Escherichia coli (STEC): a systematic review and meta-analysis protocol. BMJ Open 9:e025950","journal-title":"BMJ Open"},{"key":"6093_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/microorganisms8040587","volume":"8","author":"G Macori","year":"2020","unstructured":"Macori G, Mccarthy SC, Burgess CM et al (2020) Investigation of the causes of Shigatoxigenic Escherichia coli PCR positive and culture negative samples. Microorganisms 8:587","journal-title":"Microorganisms"},{"key":"6093_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jpids\/piv003","volume":"5","author":"A Matussek","year":"2016","unstructured":"Matussek A, Einemo IM, Jogenfors A et al (2016) Shiga toxin-producing Escherichia coli in diarrheal stool of Swedish children: evaluation of polymerase Chain reaction screening and duration of Shiga toxin shedding. J Pediatric Infect Dis Soc 5:147\u2013151","journal-title":"J Pediatric Infect Dis Soc"},{"key":"6093_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpeds.2021.06.048","volume":"237","author":"G Ardissino","year":"2021","unstructured":"Ardissino G, Vignati C, Masia C et al (2021) Bloody diarrhea and Shiga toxin-producing Escherichia coli hemolytic uremic syndrome in children: data from the ItalKid-HUS network. J Pediatr 237:34-40.e31","journal-title":"J Pediatr"},{"key":"6093_CR14","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00467-020-04560-0","volume":"35","author":"E Ylinen","year":"2020","unstructured":"Ylinen E, Salmenlinna S, Halkilahti J et al (2020) Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome. Pediatr Nephrol 35:1749\u20131759","journal-title":"Pediatr Nephrol"},{"key":"6093_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2215\/CJN.05830518","volume":"14","author":"V Fr\u00e9meaux-Bacchi","year":"2019","unstructured":"Fr\u00e9meaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P et al (2019) Complement gene variants and Shiga Toxin-producing Escherichia coli-associated hemolytic uremic syndrome: retrospective genetic and clinical study. Clin J Am Soc Nephrol 14:364\u2013377","journal-title":"Clin J Am Soc Nephrol"},{"key":"6093_CR16","doi-asserted-by":"publisher","first-page":"e0207492","DOI":"10.1371\/journal.pone.0207492","volume":"13","author":"B Ingelbeen","year":"2018","unstructured":"Ingelbeen B, Bruyand M, Mariani-Kurkjian P et al (2018) Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013\u20132016: differences with other serogroups. PLoS One 13:e0207492","journal-title":"PLoS One"},{"key":"6093_CR17","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3201\/eid2209.160304","volume":"22","author":"N Soysal","year":"2016","unstructured":"Soysal N, Mariani-Kurkdjian P, Smail Y et al (2016) Enterohemorrhagic Escherichia coli hybrid pathotype O80:H2 as a new therapeutic challenge. Emerg Infect Dis 22:1604\u20131612","journal-title":"Emerg Infect Dis"},{"key":"6093_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/fpd.2006.3.81","volume":"3","author":"EM Nielsen","year":"2006","unstructured":"Nielsen EM, Scheutz F, Torpdahl M (2006) Continuous surveillance of Shiga toxin-producing Escherichia coli infections by pulsed-field gel electrophoresis shows that most infections are sporadic. Foodborne Pathog Dis 3:81\u201387","journal-title":"Foodborne Pathog Dis"},{"key":"6093_CR19","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1542\/peds.100.1.e12","volume":"100","author":"BP Bell","year":"1997","unstructured":"Bell BP, Griffin PM, Lozano P et al (1997) Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100:E12","journal-title":"Pediatrics"},{"key":"6093_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/adc.87.4.335","volume":"87","author":"H Kitajima","year":"2002","unstructured":"Kitajima H, Ida S, Fujimura M (2002) Daily bowel movements and Escherichia coli O157 infection. Arch Dis Child 87:335\u2013336","journal-title":"Arch Dis Child"},{"key":"6093_CR21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1182\/blood.2022017860","volume":"141","author":"F Fakhouri","year":"2023","unstructured":"Fakhouri F, Schwotzer N, Fr\u00e9meaux-Bacchi V (2023) How I diagnose and treat atypical hemolytic uremic syndrome. Blood 141:984\u2013995","journal-title":"Blood"},{"key":"6093_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00467-022-05683-2","volume":"38","author":"RM De Souza","year":"2023","unstructured":"De Souza RM, Correa BHM, Melo PHM et al (2023) The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review. Pediatric Nephrol 38:61\u201375","journal-title":"Pediatric Nephrol"},{"key":"6093_CR23","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P et al (2013) Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome. N Engl J Med 368:2169\u20132181","journal-title":"N Engl J Med"},{"key":"6093_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA et al (2023) Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue. J Clin Apher 38:77\u2013278","journal-title":"J Clin Apher"},{"key":"6093_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40620-016-0288-3","volume":"30","author":"JV Walle","year":"2017","unstructured":"Walle JV, Delmas Y, Ardissino G et al (2017) Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment. J Nephrol 30:127\u2013134","journal-title":"J Nephrol"},{"key":"6093_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/microorganisms7010015","volume":"7","author":"S Buelli","year":"2019","unstructured":"Buelli S, Zoja C, Remuzzi G, Morigi M (2019) Complement activation contributes to the pathophysiology of Shiga toxin-associated hemolytic uremic syndrome. Microorganisms 7:15","journal-title":"Microorganisms"},{"key":"6093_CR27","doi-asserted-by":"publisher","unstructured":"Garnier A, Brochard K, Kwon T, Sellier-Leclerc AL, Lahoche A, Launay EA, Nobili F, Caillez M, Taque S, Harambat J, Michel-Bourdat G, Guigonis V, Fila M, Cloarec S, Djamal-Dine D, de Parscaux L, Allard L, Salomon R, Ulinski T, Fr\u00e9meaux-Bacchi V, Morin C, Olivier-Abbal P, Colineaux H, Auriol F, Arnaud C, Kieffer I, Brusq C (2023) Efficacy and safety of eculizumab in pediatric patients affected by shiga toxin-related hemolytic and uremic syndrome: a randomized, placebo-controlled trial. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.0000000000000182","DOI":"10.1681\/ASN.0000000000000182"},{"key":"6093_CR28","doi-asserted-by":"publisher","first-page":"e20162452","DOI":"10.1542\/peds.2016-2452","volume":"140","author":"SR Parikh","year":"2017","unstructured":"Parikh SR, Lucidarme J, Bingham C et al (2017) Meningococcal B vaccine failure with a penicillin-resistant strain in a young adult on long-term eculizumab. Pediatrics 140:e20162452","journal-title":"Pediatrics"},{"key":"6093_CR29","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/j.vaccine.2018.03.087","volume":"36","author":"D Reher","year":"2018","unstructured":"Reher D, Fuhrmann V, Kluge S, Nierhaus A (2018) A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal haemoglobinuria receiving eculizumab. Vaccine 36:2507\u20132509","journal-title":"Vaccine"},{"key":"6093_CR30","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","volume":"66","author":"LA McNamara","year":"2017","unstructured":"McNamara LA, Topaz N, Wang X et al (2017) High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep 66:734\u2013737","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6093_CR31","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E et al (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844\u20131859","journal-title":"Clin J Am Soc Nephrol"},{"key":"6093_CR32","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.1002\/humu.21256","volume":"31","author":"TK Maga","year":"2010","unstructured":"Maga TK, Nishimura CJ, Weaver AE et al (2010) Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 31:E1445\u2013E1460","journal-title":"Hum Mutat"},{"key":"6093_CR33","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1111\/ajt.12297","volume":"13","author":"M Alberti","year":"2013","unstructured":"Alberti M, Valoti E, Piras R et al (2013) Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Am J Transplant 13:2201\u20132206","journal-title":"Am J Transplant"},{"key":"6093_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00467-015-3207-2","volume":"31","author":"C Caillaud","year":"2016","unstructured":"Caillaud C, Zaloszyc A, Licht C et al (2016) CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS). Pediatr Nephrol 31:157\u2013161","journal-title":"Pediatr Nephrol"},{"key":"6093_CR35","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00467-022-05694-z","volume":"38","author":"C Galvez","year":"2023","unstructured":"Galvez C, Krall P, Rojas A et al (2023) HUS with mutations in CFH and STEC infection treated with eculizumab in a 4-year-old girl. Pediatr Nephrol 38:1195\u20131203","journal-title":"Pediatr Nephrol"},{"key":"6093_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/20469047.2019.1616458","volume":"40","author":"ME \u00c7elakil","year":"2020","unstructured":"\u00c7elakil ME, Y\u00fccel BB, Bek K (2020) CFH and CFB mutations in Shiga toxin-associated haemolytic uraemic syndrome in a 6-year-old boy. Paediatr Int Child Health 40:129\u2013131","journal-title":"Paediatr Int Child Health"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06093-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-06093-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06093-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T15:05:26Z","timestamp":1702911926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-06093-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["6093"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-06093-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the legal guardians for submission of the case report to the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}